A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
Status:
Completed
Trial end date:
2014-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of ASP4901 with placebo in patients with
benign prostatic hyperplasia. The safety and tolerability of ASP4901 will also be evaluated.